Frozen Shoulder Treatment Market

Frozen shoulder is the general name for mucosal bursitis, which is a shoulder disease that limits the range of motion. In the case of frozen shoulder, the tissue in the shoulder joint will become denser, and the scar tissue will develop over time. Common symptoms include swelling, pain, and stiffness. Decreased shoulder movement will increase its stiffness. Prolonged inactivity due to injury, disease or surgery also increases sensitivity to inflammation and adhesions, which are hard tissue bands.

Treatment methods for frozen shoulder include medication, joint exercises, physical therapy, and surgery.

Frozen Shoulder Treatment Market contains market size and forecasts of Frozen Shoulder Treatment in Global, including the following market information:

Global Frozen Shoulder Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Frozen Shoulder Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Frozen Shoulder Treatment include GlaxoSmithKline plc, Contract Pharmacal Corp, Amneal Pharmaceuticals, Inc., Vintage Pharma, Dr. Reddy's Laboratories Ltd, Marksans Pharma, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. and Glenmark Pharmaceuticals Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Frozen Shoulder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Frozen Shoulder Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Frozen Shoulder Treatment Market Segment Percentages, by Type, 2021 (%)

Medication

Joint Movement

Physical Therapy

Surgery

Others

Global Frozen Shoulder Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Frozen Shoulder Treatment Market Segment Percentages, by Application, 2021 (%)

Hospitals

Homecare

Specialty Clinics

Others

Global Frozen Shoulder Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Frozen Shoulder Treatment Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Frozen Shoulder Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Frozen Shoulder Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

GlaxoSmithKline plc

Contract Pharmacal Corp

Amneal Pharmaceuticals, Inc.

Vintage Pharma

Dr. Reddy's Laboratories Ltd

Marksans Pharma

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Glenmark Pharmaceuticals Ltd.

Perrigo Company plc

Johnson & Johnson Services, Inc.